Evidence map›Paper›PMID 35465155›Full record

ArticleComputational and structural biotechnology journal2022

Identification of dynamic driver sets controlling phenotypical landscapes.

Silke D Werle, Nensi Ikonomi, Julian D Schwab, Johann M Kraus, Felix M Weidner, K Lenhard Rudolph, Astrid S Pfister, Rainer Schuler, Michael Kühl, Hans A Kestler

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Silke D WerleInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Nensi IkonomiInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Julian D SchwabInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Johann M KrausInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Felix M WeidnerInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
K Lenhard RudolphLeibniz Institute of Aging - Fritz Lipman Institute, 07745 Jena, Thuringia, Germany.
Astrid S PfisterInstitute of Biochemistry and Molecular Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Rainer SchulerInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Michael KühlInstitute of Biochemistry and Molecular Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.
Hans A KestlerInstitute of Medical Systems Biology, Ulm University, 89081 Ulm, Baden-Wuerttemberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlling phenotypical landscapes is of vital interest to modern biology. This task becomes highly demanding because cellular decisions involve complex networks engaging in crosstalk interactions. Previous work on control theory indicates that small sets of compounds can control single phenotypes. However, a dynamic approach is missing to determine the drivers of the whole network dynamics. By analyzing 35 biologically motivated Boolean networks, we developed a method to identify small sets of compounds sufficient to decide on the entire phenotypical landscape. These compounds do not strictly prefer highly related compounds and show a smaller impact on the stability of the attractor landscape. The dynamic driver sets include many intervention targets and cellular reprogramming drivers in human networks. Finally, by using a new comprehensive model of colorectal cancer, we provide a complete workflow on how to implement our approach to shift from

Indexed as

Boolean networkCellular phenotype controlDynamic driverImplicantsIntervention targetsNetwork dynamics

Identifiers

PMID35465155
PMCPMC9010550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.